Sustainability & Climate

The meal kit giant partners with the celebrity chef for an Italian-inspired menu, a strategic move to capture a larger slice of the competitive market.

Stream Realty Partners sells two massive, Tesla-leased buildings in its Empire West project to BGO, signaling peak demand for prime industrial real estate.

Ferdi Porsche's revived Ice Race expands to Montana, blending high-octane racing with art, music, and luxury for a unique winter motorsport festival.

New data shows gender-diverse firms outperform peers financially, yet women hold only 6% of CEO roles at top companies, highlighting a persistent gap.

With the appointment of Mark Amelio, Stanton Chase signals a strategic push to dominate the fierce talent wars in the healthcare and consumer markets.

Agile Defense has won a coveted phase one spot on the Alliant 3 contract, positioning it to deliver AI and cyber solutions to the U.S. government.

New data reveals frozen food is no longer a backup but a core part of meal planning, driven by nutrition, affordability, and a desire to reduce food waste.

Explorer New Frontier Minerals announces a massive exploration target of up to 473,000 tonnes of copper, outlining a clear path to production in Australia.

EchoStor secures its spot on CRN's Elite 150 list again, fueled by strategic acquisitions, top industry awards, and a focus on complex enterprise IT.

International Tower Hill Mines, flush with new capital, is set to advance its massive 13.6M oz Livengood Gold Project through feasibility and permitting.

Toymaker JAKKS Pacific launches an ambitious new platform targeting the multi-billion dollar anime, manga, and creator markets. Can it beat the competition?

How a consumer-voted award for Jumex's new drink signals a major shift in the multi-billion dollar hydration industry and a new era for the legacy brand.

BioNexus Gene Lab appoints Matthew Barsing to lead its Chemrex subsidiary, signaling a strategic overhaul from industrial chemicals to biotech and advanced tech.

Satellogic launches its Aleph Observer service, shifting the satellite industry from ad-hoc snapshots to persistent, large-scale global monitoring.

Most hospitals have static defenses ill-equipped for modern threats. A new, free framework offers a clinically-informed path to a dynamic Zero Trust posture.

As cardiovascular disease affects nearly half of US adults, experts are urging a shift to existing, life-saving therapies that are widely ignored.

Verrica Pharmaceuticals heads to a key investor conference with strong YCANTH sales, a promising pipeline for warts and skin cancer, and high expectations.

A brief delay in Avidity's stockholder vote signals the final, complex steps before its acquisition by Novartis and the launch of a new spin-off.

With a novel skin drug launched, Pelthos Therapeutics heads to a key conference. Can its focused strategy convince Wall Street of its blockbuster potential?

With key investor conferences looming, Phathom Pharmaceuticals is set to showcase strong VOQUEZNA sales and a clear path to 2026 profitability.